In focus
Latest feed
From Tragedy to Triumph: How Kiran Mazumdar‑Shaw Turned Personal Loss into a Global Biosimilar Breakthrough
How a Personal Tragedy Drove Kiran Mazumdar‑Shaw to Pioneer Cancer Biosimilars at Biocon
A Game Changer? Wockhardt's Zaynich Secures Landmark US FDA Nod for Stubborn UTIs
A Major Breakthrough: Wockhardt's Zaynich Gets US FDA Nod, Offering New Hope Against Stubborn UTIs
